Eikon Therapeutics

Director, IT Computer System Validation & Quality Assurance

Millbrae, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalIndustries

Requirements

Candidates should possess a postgraduate degree with over 10 years of experience or a bachelor's degree with over 12 years of experience in computer system validation and quality assurance within the biotech or pharmaceutical industry. In-depth knowledge of regulatory requirements such as FDA and GxP pertaining to computer system validation and quality assurance is essential, along with proficiency in writing validation documentation and strong analytical, problem-solving, leadership, and communication skills.

Responsibilities

The Director, IT Computer System Validation & Quality Assurance will define and drive the global strategy for CSV and software QA, establish governance for validation lifecycle management, and collaborate with IT, Clinical, and Regulatory teams. They will own and evolve the organization's CSV framework, ensure validation activities meet regulatory and business requirements for systems like Veeva Vaults, QMS, Safety systems, and custom applications, and develop/execute strategies for computer system validation. Responsibilities also include establishing and maintaining validation protocols, providing leadership to the Software Quality Assurance team, creating/reviewing/maintaining documentation, preparing validation reports for submissions, designing/overseeing test case execution, identifying deviations, optimizing processes, developing training programs, staying current with regulations, and ensuring audit readiness.

Skills

Computer System Validation
Quality Assurance
Biotechnology
Pharmaceutical Industry
Regulatory Requirements
FDA
GxP
Validation Documentation
Analytical Skills
Problem-Solving
Leadership
Communication

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters
2019Year Founded
$750.8MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, BiotechnologyIndustries
201-500Employees

Benefits

401(k) Company Match
Medical (premiums covered by Eikon at 95%)
Dental Insurance
Vision Insurance
Mental Health Support
Unlimited Paid Time Off
Paid Holidays
Life Insurance
Enhanced Parental Leave
Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.
Integrating new clinical-stage assets may delay drug development timelines.
Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.
The company integrates AI and automation for large-scale molecular interaction studies.
Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.
Partnerships with AI firms enhance Eikon's drug candidate identification.
Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI